← Back to Search

SIFI local anesthesia for Hip Fracture

N/A

Waitlist Available

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 48 hours

Awards & highlights

Study Summary

This trial aims to compare two commonly used anesthesia techniques for hip fracture surgery in adults. The study will look at how each technique affects the patients' pain levels and the amount of pain medication needed after surgery

Who is the study for?

This trial is for adults over 18 who are having hip fracture surgery at the University of Alberta Hospital and can receive multimodal analgesia with a nerve block. It's not suitable for those who have conditions that make nerve blocks unsafe or those who don't consent to this type of anesthesia.Check my eligibility

What is being tested?

The study compares two local/regional anesthesia techniques in hip fracture surgeries: femoral nerve block (FNB) and suprainguinal fascia iliaca block (SiFi). Patients will be randomly assigned to one technique, focusing on pain levels and postoperative painkillers needed.See study design

What are the potential side effects?

While specific side effects aren't detailed here, typical risks associated with regional anesthesia may include discomfort at the injection site, potential nerve damage, bleeding, infection, or inadequate pain relief.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 48 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~48 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Postoperative analgesics administered

Postoperative pain

Secondary outcome measures

Complications

Mobilization

Time to readiness for discharge

Side effects data

From 2019 Phase 4 trial • 1561 Patients • NCT03472469

Death

100%

80%

60%

40%

20%

Study treatment Arm

MAST MMPR - Escalating Dose Arm

Original MMPR - Descending Dose Arm

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SIFI local anesthesiaExperimental Treatment1 Intervention

Subjects randomized to the SiFi arm will have an ultrasound-guided suprainguinal fascia iliaca block performed preoperatively in the anesthesia block room with 40ml of ropivacaine local anesthetic.

Group II: FNB local anesthesiaActive Control1 Intervention

Subjects randomized to the FNB arm will have an ultrasound-guided femoral nerve block performed preoperatively in the anesthesia block room with 20ml of ropivacaine local anesthetic.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Regional anesthesia

2018

Completed Phase 4

~2320

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

889 Previous Clinical Trials

385,071 Total Patients Enrolled

1 Trials studying Hip Fracture

220 Patients Enrolled for Hip Fracture

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently eligible to apply for participation in this ongoing medical study?

"The information available on clinicaltrials.gov indicates that recruitment for this particular study is closed. Despite being posted on May 1st, 2024 and last edited on February 29th, 2024, the trial is no longer enrolling participants. However, there are currently 673 other ongoing studies actively seeking eligible candidates."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SiFi vs FNB Local Anesthesia for Hip Fracture Surgeries

Derek Dillane 2024. "SiFi vs FNB Local Anesthesia for Hip Fracture Surgeries". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06296758.